RecruitingNot ApplicableNCT07447011

Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea


Sponsor

Cairo University

Enrollment

40 participants

Start Date

Feb 4, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

glaucoma is prevalent among obstructive sleep apnea (OSA). contnous passive airway pressure is main treatment of OSA. lifestyle corrections also recommended


Eligibility

Min Age: 30 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring whether lifestyle changes — such as weight loss and treatment of sleep apnea — can improve glaucoma, an eye condition where increased pressure in the eye damages the optic nerve and can lead to vision loss. The study focuses on the connection between obstructive sleep apnea, obesity, and open-angle glaucoma. **You may be eligible if:** - You have been diagnosed with obstructive sleep apnea (a sleep disorder where breathing repeatedly stops and starts during sleep) - You are classified as obese - You have open-angle glaucoma with elevated eye pressure (ocular hypertension) **You may NOT be eligible if:** - You have significant heart disease - You have kidney disease - You have liver disease Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALlifetyle corrections and CPAP

twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group I will apply CPAP during night sleeping daily for three month. group I will apply lifestyle corrections (low calories diet intake and 3-session per-week 40-minute treadmill walking for three month.

OTHERCPAP

twenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group II will apply CPAP during night sleeping daily for three month.


Locations(1)

Cairo University

Giza, Dokki, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07447011


Related Trials